In a regulatory filing, HCA Healthcare (HCA) chief ethics officer Kathleen Whalen disclosed the sale of 1,474 common shares of the company on November 14 at a price of $357.99 per share.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target lowered to $392 from $396 at Barclays
- HCA Healthcare price target raised to $400 from $395 at Wells Fargo
- HCA Healthcare price target raised to $400 from $390 at Oppenheimer
- HCA Healthcare price target lowered to $440 from $450 at TD Cowen
- HCA Healthcare price target lowered to $406 from $427 at Morgan Stanley